共 50 条
- [21] A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of myobloc (Botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet: A double-blinded, placebo-controlled trialDERMATOLOGIC SURGERY, 2003, 29 (05) : 508 - 515Baumann, LSlezinger, AVujevich, JHalem, MBryde, JBlack, LDuncan, R
- [22] Efficacy and Safety of Clearing Heat and Detoxifying Injection in the Treatment of Influenza: A Randomized, Double-Blinded, Placebo-Controlled TrialEVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014Liu, YuHuang, YuhongWei, BaolinLiu, XinqiaoZhang, YaqingHuang, XiaominTan, YupingSun, Zengtao
- [23] Efficacy and safety of Suhuang Zhike Capsules in the treatment of asthma: A multicenter, randomized, double-blinded, placebo-controlled trialEUROPEAN RESPIRATORY JOURNAL, 2024, 64Pan, YilinHua, WenShi, CuiqinBao, WupingYu, LiShen, HuahaoZhang, Min
- [24] The efficacy of a commercial shampoo and whirlpooling in the treatment of canine pruritus - a double-blinded, randomized, placebo-controlled studyVETERINARY DERMATOLOGY, 2007, 18 (06) : 427 - 431Loeflath, A.von Voigts-Rhetz, A.Jaeger, K.Schmid, M.Kuechenhoff, H.Mueller, R. S.
- [25] A randomized double-blinded placebo-controlled study to evaluate an effective ciclosporin dose for the treatment of feline hypersensitivity dermatitisVETERINARY DERMATOLOGY, 2012, 23 (05)King, StephenFavrot, ClaudeMessinger, LindaNuttall, TimSteffan, JeanForster, SophieSeewald, Wolfgang
- [26] Phase II study to evaluate the efficacy of capecitabine combined with bevacizumab as first-line treatment in elderly patients with advanced or metastatic colorectal adenocarcinomaJOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)Feliu, J.Safont, M.Salud, A.Losa, F.Garcia-Giron, C.Bosch, C.Escudero, P.Lopez, R.Madronal, C.Gonzalez-Baron, M.
- [27] A phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of andecaliximab combined with mFOLFOX6 as first-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma (GAMMA-1).JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)Shah, Manish A.Ruiz, Eduardo Patricio YanezBodoky, GyorgyStarodub, AlexanderCunningham, DavidYip, DesmondWainberg, Zev A.Bendell, Johanna C.Dung ThaiBhargava, PankajAjani, Jaffer A.
- [28] Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasisBRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (04) : 844 - 852Ryan, C.Menter, A.Guenther, L.Blauvelt, A.Bissonnette, R.Meeuwis, K.Sullivan, J.Cather, J. C.Yosipovitch, G.Gottlieb, A. B.Merola, J. F.Duffin, K. CallisFretzin, S.Osuntokun, O. O.Burge, R.Naegeli, A. N.Yang, F. E.Lin, C. -Y.Todd, K.Bleakman, A. Potts
- [29] Bimekizumab efficacy and safety in Korean patients with moderate to severe plaque psoriasis: A phase 3, randomized, placebo-controlled, double-blinded studyJOURNAL OF DERMATOLOGY, 2024, 51 (11): : 1392 - 1403Youn, Sang WoongJo, Seong JinPark, Chul JongKim, Dong HyunShin, Bong SeokJeong, Ki HeonBang, Chul HwanCross, NancyThirlwell, JackieHoepken, Bengt
- [30] A phase II/III, randomized, placebo-controlled study of bintrafusp alfa with gemcitabine plus cisplatin as first-line treatment of biliary tract cancerANNALS OF ONCOLOGY, 2020, 31 : S271 - S272Oh, D-Y.de Braud, F.Bridgewater, J.Furuse, J.Hsu, C-H.Ikeda, M.Javle, M.Moehler, M.Park, J. O.Shen, L.Yoo, C.Helwig, C.Osada, M.Borad, M.